In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
Close this windowThis post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Registered nurses are invited to apply for CESPHN’s scholarship to complete a HESA accredited immunisation course to become a qualified Authorised Nurse Immuniser in NSW. CESPHN are offering successful applicants 100% scholarship to this course (valued at $350).
Qualification: Upon completion of this course, registered nurses and midwives will have the qualification to supply and administer vaccines independently of a medical officer, as per the NSW Health Authority.
Eligibility criteria: AHPRA registered RN currently employed at a General Practice within the CESPHN region. RN must be able to register and commence course within 1 week of invitation and must successfully complete course within 20 weeks of registration. RN must not have previously attained qualification as an Authorised Nurse Immuniser.
The course: SA Health – Understanding Vaccines and the National Immunisation Program. Approximately 70 hours of online study, with a maximum of 20 weeks to complete the course.
APPLY NOW:General Practice nurse – Application Form. Applications close 30 September 2022.
The ATAGI clinical guidance on vaccination against Monkeypox was updated 26 August 2022 to include the following changes:
It is crucial that details on the Vaccine Clinic Finder are accurate. Patients rely on the VCF to find and book COVID-19 vaccinations. All COVID-19 vaccination sites must log in to VCF Connect and update their vaccine service details. Keeping VCF details up to date is a mandatory requirement of the vaccine program.
Contact coronavirus@cesphn.com.au for assistance.
All vaccine vials (expired, partially used, and empty vials), needles and syringes must be disposed of in a clinical waste bin, in accordance with local requirements. Pharmacy RUM bins (Return of Unwanted Medicines bin) are not an approved clinical waste bin.
The vaccine outer packaging (carton) should be defaced by striking through at least one panel of the carton with a permanent marker prior to disposal. All sites are required to have a documented procedure for disposal of vaccines.
Training module available:
On 26 August 2022, the new training module for Moderna (SPIKEVAX) 6 months to under 5 years was launched via the COVID-19 Vaccination Training Program website. To access the new module (3.b), learners will need to:
Consent form available:
The Moderna 6 months to under 5 years information and consent form provides key information about COVID-19 vaccines for parents and guardians of children aged 6 months to 5 years.
COVID-19 reference chart updated:
The COVID-19 vaccine comparison A3 poster was updated 26 August 2022 to include Spikevax (Moderna) Primary Course (6 months – 5 years).
Guidance on multi-dose vials updated:
The ATAGI guidelines for the correct use of multi-dose vials have been updated to include advice that is also applicable to the use of Paediatric Spikevax (Moderna) vaccine. The Paediatric Spikevax vaccine is a new formulation (blue cap purple stripe vial) consisting of a new concentration of 100 mcg/mL in multi-dose vials containing 10 doses, each 0.25mL.
ATAGI has recommended the use of Novavax for adolescents aged 12-17 years for their primary course of COVID-19 vaccination. The recommended primary course dosing schedule for Novavax COVID-19 vaccine is 2 doses, 8 weeks apart.
From 5 September 2022, bookings can be made via the Vaccine Clinic Finder. Sites may commence administering Novavax to this population immediately if they have appointments and stock available.
Novavax is not registered by the TGA for use as a booster dose in adolescents aged 12-17 years, however ATAGI have advised that Novavax can be used as a booster in this age group if no other COVID-19 vaccine brand is suitable for that person. See ATAGI recommendations on the use of a booster dose of COVID-19 vaccine
The ATAGI clinical guidance on COVID-19 vaccine administration errors provides advice on the management of a range of vaccine administration errors. The guidelines, updated 29 August 2022, includes replacement dose advice for booster doses and includes advice specific to the 6 month to <5 year age group.
The COVID-19 In-Reach Vaccination Practice Incentives Program (PIP) has been extended to 31 December 2022. See the updated PIP Payment Guidelines.
Catch up on previous Immunisation Weekly Updates.
Keep up to date with the latest information on Monkeypox.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
MEDIA RELEASE: Canterbury Head to Health service opens doors to offer free, immediate mental health support. Canterbury Head to Health opened its doors in late January, offering free and immediate support for anyone in Canterbury and the surrounding regions experiencing distress or mental health concerns.Trained professionals are providing short to…
